The map and global disease burden of chronic liver diseases are markedly changing, with
nonalcoholic fatty liver disease (NAFLD) becoming the most common cause of liver …

Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

The pathophysiology and risk factors of nonalcoholic fatty liver disease (NAFLD) among
lean patients is poorly understood and therefore investigated. We performed a meta …

Non-alcoholic fatty liver disease (NAFLD) is often thought of as the hepatic manifestation of
the metabolic syndrome and is frequently accompanied by type 2 diabetes, hypertension …

This supplement to “Metabolism, Clinical and Experimental” is dedicated to nonalcoholic
fatty liver disease (NAFLD), a disease closely linked with the insulin resistance (IR) …

Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides clinicians an overview of nonalcoholic fatty liver disease (NAFLD), potential …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease affecting approximately 25% of the global population. Although a majority of NAFLD …

As in the West, nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver
disease in Asia, with a prevalence higher than 40% in some countries. The risk factors for …

Studies have shown that nonalcoholic fatty liver disease (NAFLD) is strongly associated with
several metabolic disorders and diseases, such as obesity, type 2 diabetes mellitus, and …